Alan M. Schultz
- Virology top 1%
- HIV Research and Treatment 12
- Immunology top 10%
- Immunotherapy and Immune Responses 6
- Molecular Biology top 10%
- Glycosylation and Glycoproteins Research 5
- vaccines and immunoinformatics approaches 5
- Genetics top 10%
- Virus-based gene therapy research 5
- Cell Biology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Hepatitis B Virus Studies 4
- Herpesvirus Infections and Treatments 3
- Co-authors
- Stephen OroszlanLouis E. HendersonEllen A. GarberHidesaburô HanafusaAlan ReinManju BasuSaul RosemanUlf R. Rapp
- Cited by
- VirologyImmunologyMolecular Biology
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Alan M. Schultz
26 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 82
- Virology 476
- Immunology 360
- Molecular Biology 849
- Genetics 308
- Cell Biology 177
Countries citing papers authored by Alan M. Schultz
This map shows the geographic impact of Alan M. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan M. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan M. Schultz more than expected).
Fields of papers citing papers by Alan M. Schultz
This network shows the impact of papers produced by Alan M. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan M. Schultz. The network helps show where Alan M. Schultz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan M. Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 2 | |
| 2 | 2001 | 24 | |
| 3 | 2000 | 42 | |
| 4 | 1997 | 26 | |
| 5 | 1996 | 2 | |
| 6 | 1996 | 1 | |
| 7 | 1994 | 4 | |
| 8 | 1993 | 26 | |
| 9 | 1992 | 0 | |
| 10 | 1988 | 222 | |
| 11 | 1988 | 20 | |
| 12 | 1987 | 81 | |
| 13 | 1985 | 244 | |
| 14 | 1985 | 17 | |
| 15 | 1985 | 78 | |
| 16 | 1983 | 18 | |
| 17 | 1980 | 16 | |
| 18 | 1979 | 38 | |
| 19 | 1978 | 40 | |
| 20 | 1971 | 76 |
About Alan M. Schultz
Alan M. Schultz is a scholar working on Virology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (12 papers), Immunotherapy and Immune Responses (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (5 papers), Virus-based gene therapy research (5 papers), vaccines and immunoinformatics approaches (5 papers), Hepatitis B Virus Studies (4 papers) and Herpesvirus Infections and Treatments (3 papers). The work is most often cited by research in Virology (476 citations), Immunology (360 citations) and Molecular Biology (849 citations). Alan M. Schultz has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Stephen Oroszlan, Louis E. Henderson, Ellen A. Garber, Hidesaburô Hanafusa, Alan Rein, Manju Basu, Saul Roseman, Ulf R. Rapp, Subhash Basu and Wayne C. Koff. Their work appears in journals such as Virology, AIDS, Journal of Biological Chemistry, AIDS Research and Human Retroviruses and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.